Reports for TEVETEN
Brand name
TEVETEN
Company Name
BGP PHARMA ULC
|
Drug Identification Number
02240432 |
Ingredients
EPROSARTAN |
Ingredient Strength
400 MG |
ATC Code
C09CAC09CA |
ATC Descriptor
ANGIOTENSIN II ANTAGONISTS, PLAIN ANGIOTENSIN II ANTAGONISTS, PLAIN |
Status
CANCELLED POST MARKET
|
Shortage reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|
| TEVETEN | 2x14 | Resolved | 2017-11-20 | 2018-01-06 | 29736 |
| TEVETEN | 2 x 14 | Resolved | 2019-05-08 | 2019-10-23 | 83432 |
| TEVETEN | 14x2 | Resolved | 2020-01-13 | 2020-07-23 | 103139 |
| TEVETEN | 14x2 | Avoided shortage | 2020-09-22 | 2020-11-10 | 124713 |
| TEVETEN | 14x2 | Resolved | 2020-12-01 | 2021-02-04 | 129203 |
| TEVETEN | 2x14 | Actual shortage | 2022-10-05 | 2022-10-05 | 171165 |
Showing 1 to 6 of 6
Discontinuation reports
| Brand name | Packaging Size | Status | Date Created | Date Updated | Reports |
|---|
Showing 1 to 0 of 0